Paula Silverman, MD

Universitys Hospital Case Medical CenterCleveland, Ohio - 44106 (216-844-5606) |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2008

Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer
July 2008 - November 2012
Breast Neoplasms
Placebo
Wx-671



